Press Releases

5.28.2016 – Mystic Pharmaceuticals Receives Japanese Patent For Innovative
Pharmaceutical Packaging And Delivery Technology

4.19.2016 – Mystic Pharmaceuticals Receives US Patent For Novel Nose To Brain
Delivery Of Therapeutics To Treat Neurodegenerative Disorders

10.29.2014 – Mystic Pharmaceuticals Introduces ArrowFish™ Nasal Vaccine and Drug Delivery System

07.30.2014 – Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology

07.14.2014 – Mystic Pharmaceuticals Unveils The Next Generation Of Patient-Centric Sublingual Drug Delivery Devices

04.08.2014 – Mystic Pharmaceuticals Receives U.S. Patent for Human-Centric Unit Dose Drug Packaging and Delivery Technology

03.19.2014 – Mystic Pharmaceuticals Appoints Gerald D. Cagle Ph.D. and Grady Rylander M.D. to Scientific Advisory Board

03.07.2014 – Mystic Pharmaceuticals to Present at 6th Ocular Diseases & Drug Discovery Conference

10.01.2013 – Mystic Pharmaceuticals Receives Notices Of Allowance From Japan and China on Drug Delivery Platform Technologies

09.17.2013 – Mystic Pharmaceuticals Receives Multiple US Patent Office Notices Of Allowance on Drug Delivery Platform Technologies

04.04.2013 – Mystic Pharmaceuticals to Present at the 2013 International Nasal znd Buccal Drug Delivery Conference

03.07.2013 – Mystic Pharmaceuticals to Present at 5th Ocular Diseases & Drug Development Conference

02.08.2013 – Mystic Pharmaceuticals Receives U.S. Patent for Intranasal Delivery Technology For Pharmaceuticals and Biologics

09.20.2012 – Mystic Pharmaceuticals to Present at the 2nd Annual Partnerships In Drug Delivery Conference In Boston

09.12.2012 – Mystic Pharmaceuticals Receives U.S. Patent for Manufacturing Innovative Unit Dose Packaging for Drugs and Biologics

04.11.2012 – Mystic Pharmaceuticals to Present at the International Nasal and Buccal Drug Delivery Conference.

01.12.2012 – Mystic Pharmaceuticals to Present at 4th Ocular Diseases & Drug Discovery Conference Dose Packaging and Delivery Technology for Drugs and Biologics.

11.08.2011 – Mystic Pharmaceuticals Receives U.S. Patent for Innovative Unit Dose Packaging and Delivery Technology for Drugs and Biologics.

07.12.2011 – Mystic Pharmaceuticals to Present at Infocast 9th Annual Biodefense Vaccines and Therapeutics Conference in Washington D.C.

06.13.2011 – Mystic Pharmaceuticals Receives U.S. Patent for Novel Packaging Technology for Drugs and Biologics

11.08.2010 – Mystic Pharmaceuticals Receives Qualifying Therapeutic Discovery Grant For Drug Delivery Technology

05.05.2010 – Mystic Pharmaceuticals Receives U.S. Patent For Needle-Free Vaccine and Drug Delivery Technology

10.08.2009 – MacuCLEAR and Mystic Successfully Complete Phase Ib Clinical Trial for Macular Degeneration

01.13.2009 – MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial

09.15.2008 – Mystic Pharmaceuticals CEO To Present At HHS BARDA Public Health Emergency Medical Countermeasures Workshop

07.09.2008 – Mystic CEO Timothy Sullivan Named To Top One Hundred Notable People In Medical Device Industry

05.14.2008 - Mystic Pharmaceuticals Expands Management, Engineering and Scientific Team with Key Hires

01.07.2008 – Mystic Pharmaceuticals CEO Presents At ONEMEDPLACE Finance Forum

02.14.2007 – Mystic Pharmaceuticals Expands Texas Clinical Manufacturing R&D Facility